Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHL TelemedicineXSWX:SHLTN 53 Cyclically Adjusted PS Ratio is 0.44 as of Jul. 30, 2026, which is 73% below its 10-year median of 1.60. GuruFocus rates XSWX:SHLTN with a GF Score™ of 53/100 and a GF Value™ of CHF2.62 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 358 Healthcare Providers & Services companies, SHL Telemedicine ranks better than 77.37% on this metric.
The historical rank and industry rank for SHL Telemedicine's Cyclically Adjusted PS Ratio or its related term are showing as below:
XSWX:SHLTN'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.19 Med: 1.6 Max: 5.24
Current: 0.44
During the past 13 years, SHL Telemedicine's highest Cyclically Adjusted PS Ratio was 5.24. The lowest was 0.19. And the median was 1.60.
XSWX:SHLTN's Cyclically Adjusted PS Ratio is ranked better than 77.37% of 358
companies
in the Healthcare Providers & Services industry
Industry Median: 1.13
vs XSWX:SHLTN: 0.44
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
SHL Telemedicine's adjusted revenue per share data of for the fiscal year that ended in Dec25 was CHF2.182. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is CHF2.46 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
SHL Telemedicine (XSWX:SHLTN) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
SHL Telemedicine Cyclically Adjusted PS Ratio Related Terms
SHL Telemedicine Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine Cyclically Adjusted PS Ratio Chart
XSWX:SHLTN vs VEEV, BTSG, HQY: Cyclically Adjusted PS Ratio Comparison
For the Health Information Services subindustry, SHL Telemedicine's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Cyclically Adjusted PS Ratio falls into.
SHL Telemedicine Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
SHL Telemedicine's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.44 mean?
SHL Telemedicine (XSWX:SHLTN) has a Cyclically Adjusted PS Ratio of 0.44 as of Jul. 30, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on SHL Telemedicine and its competitors. This is 73% below median its historical median of 1.60. Over the past decade, SHL Telemedicine's Cyclically Adjusted PS Ratio has ranged from 0.19 to 5.24. According to the industry distribution chart, SHL Telemedicine ranks #81 out of 358 companies in the Healthcare Providers & Services industry, placing it in the top 22.6%.
Is SHL Telemedicine's Cyclically Adjusted PS Ratio too high?
SHL Telemedicine's current Cyclically Adjusted PS Ratio of 0.44 is 73% below median its 10-year median of 1.60. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 5.24. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.13. SHL Telemedicine's value of 0.44 is 61.1% below this industry median. Based on the distribution chart, SHL Telemedicine ranks #81 out of 358 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, SHL Telemedicine has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Cyclically Adjusted PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #81 out of 358 companies for Cyclically Adjusted PS Ratio. This places SHL Telemedicine in the top 23% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PS Ratio is 1.13. SHL Telemedicine's value of 0.44 is 61.1% below this benchmark. Historically, SHL Telemedicine's own Cyclically Adjusted PS Ratio has ranged from 0.19 to 5.24 over the past decade. While the company's 10-year median is 1.60 vs. the industry median of 1.13, SHL Telemedicine has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.13, based on 358 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current Cyclically Adjusted PS Ratio of 0.44 is 61.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Cyclically Adjusted PS Ratio is 0.44, which is 73% below median its own 10-year median of 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
Based on GuruFocus' analysis, SHL Telemedicine (XSWX:SHLTN) is currently considered Possible Value Trap. The stock's GF Value™ is CHF2.62, compared to a current price of CHF1.08 — trading 58.8% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.44, which is 73% below median its 10-year median of 1.60 and 61.1% below the Healthcare Providers & Services industry median of 1.13. SHL Telemedicine's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For SHL Telemedicine (XSWX:SHLTN), the current Cyclically Adjusted PS Ratio is 0.44 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (XSWX:SHLTN) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of CHF1.08 is trading 58.8% below its estimated GF Value™ of CHF2.62.
GuruFocus considers SHL Telemedicine to be Possible Value Trap.
Key valuation signals for XSWX:SHLTN:
Cyclically Adjusted PS Ratio: 0.44 (73% below median its 10-year median of 1.60)
GF Value™: CHF2.62 vs. price of CHF1.08 (58.8% below fair value)
Industry Position: 61.1% below the Healthcare Providers & Services median (#81 of 358)
No single metric tells the full story. See the XSWX:SHLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
53GF Score
Get the complete analysis for XSWX:SHLTN
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SHLTN has been successfully added to your 
